These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 14578129)
1. Polymorphism in the thymidylate synthase promoter enhancer region modifies the risk and survival of colorectal cancer. Chen J; Hunter DJ; Stampfer MJ; Kyte C; Chan W; Wetmur JG; Mosig R; Selhub J; Ma J Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):958-62. PubMed ID: 14578129 [TBL] [Abstract][Full Text] [Related]
2. Polymorphism in the thymidylate synthase promoter enhancer region and risk of colorectal adenomas. Chen J; Kyte C; Chan W; Wetmur JG; Fuchs CS; Giovannucci E Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2247-50. PubMed ID: 15598787 [TBL] [Abstract][Full Text] [Related]
3. A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil. Iacopetta B; Grieu F; Joseph D; Elsaleh H Br J Cancer; 2001 Sep; 85(6):827-30. PubMed ID: 11556832 [TBL] [Abstract][Full Text] [Related]
4. Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers. Morganti M; Ciantelli M; Giglioni B; Putignano AL; Nobili S; Papi L; Landini I; Napoli C; Valanzano R; Cianchi F; Boddi V; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E Eur J Cancer; 2005 Sep; 41(14):2176-83. PubMed ID: 16182121 [TBL] [Abstract][Full Text] [Related]
5. Thymidylate synthase gene promoter polymorphisms are associated with TSmRNA expressions but not with microsatellite instability in colorectal cancer. Calascibetta A; Cabibi D; Martorana A; Sanguedolce G; Rausa L; Feo S; Dardanoni G; Sanguedolce R Anticancer Res; 2004; 24(6):3875-80. PubMed ID: 15736425 [TBL] [Abstract][Full Text] [Related]
6. Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy. Lecomte T; Ferraz JM; Zinzindohoué F; Loriot MA; Tregouet DA; Landi B; Berger A; Cugnenc PH; Jian R; Beaune P; Laurent-Puig P Clin Cancer Res; 2004 Sep; 10(17):5880-8. PubMed ID: 15355920 [TBL] [Abstract][Full Text] [Related]
7. Association of thymidylate synthase gene polymorphism with its mRNA and protein expression and with prognosis in gastric cancer. Ishida Y; Kawakami K; Tanaka Y; Kanehira E; Omura K; Watanabe G Anticancer Res; 2002; 22(5):2805-9. PubMed ID: 12530000 [TBL] [Abstract][Full Text] [Related]
8. Associations between polymorphisms in the thymidylate synthase gene, the expression of thymidylate synthase mRNA and the microsatellite instability phenotype of colorectal cancer. Merkelbach-Bruse S; Hans V; Mathiak M; Sanguedolce R; Alessandro R; Rüschoff J; Büttner R; Houshdaran F; Gullotti L Oncol Rep; 2004 Apr; 11(4):839-43. PubMed ID: 15010882 [TBL] [Abstract][Full Text] [Related]
9. [Thymidylate synthase gene promoter polymorphism in patients with advanced head and neck cancer treated by radio- and 5-fluorouracil chemotherapy]. Kiss-László Z; Nagy B; Thurzó L; Szabó J Magy Onkol; 2006; 50(1):33-7. PubMed ID: 16617381 [TBL] [Abstract][Full Text] [Related]
10. [Frequency of TS1494del6 polymorphism in colorectal patients from west of Mexico]. Gallegos-Arreola MP; Peralta-Leal V; Morgan-Villela G; Puebla-Pérez AM Rev Invest Clin; 2008; 60(1):21-30. PubMed ID: 18589584 [TBL] [Abstract][Full Text] [Related]
11. Tumor thymidylate synthase 1494del6 genotype as a prognostic factor in colorectal cancer patients receiving fluorouracil-based adjuvant treatment. Dotor E; Cuatrecases M; Martínez-Iniesta M; Navarro M; Vilardell F; Guinó E; Pareja L; Figueras A; Molleví DG; Serrano T; de Oca J; Peinado MA; Moreno V; Germà JR; Capellá G; Villanueva A J Clin Oncol; 2006 Apr; 24(10):1603-11. PubMed ID: 16575011 [TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of thymidylate synthase gene 5'- and 3'-untranslated region and risk of gastric cancer in Koreans. Yim DJ; Kim OJ; An HJ; Kang H; Ahn DH; Hwang SG; Oh D; Kim NK Anticancer Res; 2010 Jun; 30(6):2325-30. PubMed ID: 20651387 [TBL] [Abstract][Full Text] [Related]
13. Polymorphism of thymidylate synthase gene and chemosensitivity of 5-fluorouracil regimen in metastatic gastrointestinal cancer. Cui YH; Liu TS; Zhuang RY; Gao HJ; Li H J Dig Dis; 2009 May; 10(2):118-23. PubMed ID: 19426394 [TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in the enhancer region of the thymidylate synthase gene are associated with thymidylate synthase levels in normal tissues but not in malignant tissues of patients with colorectal cancer. Mauritz R; Giovannetti E; Beumer IJ; Smid K; Van Groeningen CJ; Pinedo HM; Peters GJ Clin Colorectal Cancer; 2009 Jul; 8(3):146-54. PubMed ID: 19632929 [TBL] [Abstract][Full Text] [Related]
15. Polymorphism in the thymidylate synthase promoter enhancer region is not an efficacious marker for tumor sensitivity to 5-fluorouracil-based oral adjuvant chemotherapy in colorectal cancer. Tsuji T; Hidaka S; Sawai T; Nakagoe T; Yano H; Haseba M; Komatsu H; Shindou H; Fukuoka H; Yoshinaga M; Shibasaki S; Nanashima A; Yamaguchi H; Yasutake T; Tagawa Y Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3700-4. PubMed ID: 14506161 [TBL] [Abstract][Full Text] [Related]
16. Thymidylate synthase polymorphism and microsatellite instability: association in colorectal cancer. Calascibetta A; Rausa L; Gullotti L; Buettner R; Sanguedolce R Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1377-9. PubMed ID: 15571262 [TBL] [Abstract][Full Text] [Related]
17. Thymidylate synthase promoter polymorphism, interaction with folate intake, and risk of colorectal adenomas. Ulrich CM; Bigler J; Bostick R; Fosdick L; Potter JD Cancer Res; 2002 Jun; 62(12):3361-4. PubMed ID: 12067974 [TBL] [Abstract][Full Text] [Related]
18. Combination of polymorphisms within 5' and 3' untranslated regions of thymidylate synthase gene modulates survival in 5 fluorouracil-treated colorectal cancer patients. Fernández-Contreras ME; Sánchez-Hernández JJ; González E; Herráez B; Domínguez I; Lozano M; García De Paredes ML; Muñoz A; Gamallo C Int J Oncol; 2009 Jan; 34(1):219-29. PubMed ID: 19082493 [TBL] [Abstract][Full Text] [Related]
19. [Pharmacogenetic studies on the prediction of efficacy and toxicity of fluoropyrimidine-based adjuvant therapy in colorectal cancer]. Kralovánszky J; Adleff V; Hitre E; Pap E; Réti A; Komlósi V; Budai B Magy Onkol; 2007; 51(2):113-25. PubMed ID: 17660867 [TBL] [Abstract][Full Text] [Related]
20. Thymidylate synthase enhancer region polymorphism not related to susceptibility to acute lymphoblastic leukemia in the Kashmir population. Nazki FH; Masood A; Banday MA; Bhat A; Ganai BA Genet Mol Res; 2012 Apr; 11(2):906-17. PubMed ID: 22576918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]